Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection
- 1 January 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (1), 10-15
- https://doi.org/10.1128/aac.25.1.10
Abstract
Inadequate penetration of antiviral agents through the stratum corneum of the skin may be one of the limiting factors in the topical therapy of recurrent cutaneous herpes simplex virus infections in humans. In vitro studies of the penetration of the nucleoside analog acyclovir (ACV) through guinea pig skin demonstrated a marked increase in drug flux when ACV was formulated in dimethyl sulfoxide (DMSO), compared with water or polyethylene glycol (PEG) as the vehicle. To examine whether the increased transcutaneous flux of ACV effected by DMSO was meaningful in vivo, topical 5% ACV in DMSO was evaluated for the treatment of cutaneous herpes simplex virus infection in guinea pigs and compared with topical 5% ACV in PEG. When compared with infection sites treated with the vehicle alone, ACV in DMSO produced a greater percent reduction than did ACV in PEG in median lesion number (8 versus 58%; P less than 0.001), median lesion area (35 versus 73%; P = 0.001), and median lesion virus titer (21 versus 84%; P = 0.08). We conclude that DMSO is a highly effective vehicle for topical administration of ACV and is superior to PEG in our model. Careful choice of vehicle and consideration of transcutaneous penetration may be important for realization of the full potential of topical antiviral therapy in humans.This publication has 22 references indexed in Scilit:
- A Trial of Topical Acyclovir in Genital Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1982
- Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea PigsThe Journal of Infectious Diseases, 1982
- Regional Differences in the Growth of Normal and Neoplastic CellsScience, 1982
- CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACYCLOVIR IN HEART-TRANSPLANT PATIENTS WITH MUCOCUTANEOUS HERPES SIMPLEX INFECTIONSThe Lancet, 1981
- Acyclovir in Oral and Ganglionic Herpes Simplex Virus InfectionsThe Journal of Infectious Diseases, 1979
- Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigsArchiv für die gesamte Virusforschung, 1978
- CUTANEOUS HERPES SIMPLEX VIRUS INFECTION OF GUINEA PIGS AS A MODEL FOR ANTIVIRAL CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1977
- Guinea Pig Model for Cutaneous Herpes Simplex Virus InfectionJournal of Investigative Dermatology, 1974
- Impairment of Skin Barrier Function by DepilatoriesJournal of Investigative Dermatology, 1972
- Herpes simplex virus skin infection in man treated with idoxuridine in dimethyl sulphoxide. Results of double-blind controlled trial.BMJ, 1966